Aclaris Therapeutics News

Aclaris Therapeutics | 8-K: Current report

Jul 16 16:32 ET

Aclaris Therapeutics | 8-K: Current report

Jun 7 16:20 ET

Aclaris Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 7 17:00 ET

Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update

May 7 16:23 ET

Aclaris Therapeutics | DEFA14A: Others

Apr 25 07:05 ET

Aclaris Therapeutics | DEF 14A: Definitive information statements

Apr 25 07:05 ET

Aclaris Therapeutics | 8-K: Current report

Mar 19 16:33 ET

Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update

Feb 27 07:20 ET

Aclaris Therapeutics | 8-K/A: Current report (Amendment)

Feb 5 16:36 ET

Aclaris Therapeutics | 8-K: Current report

Feb 5 16:35 ET

Aclaris Therapeutics | 8-K: Current report

Jan 19 00:00 ET

Aclaris Therapeutics | 8-K: Current report

Dec 19, 2023 16:15 ET

Aclaris Therapeutics | 8-K: Current report

Nov 13, 2023 07:42 ET

Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

Nov 6, 2023 07:15 ET

Aclaris Therapeutics | 8-K: Current report

Sep 18, 2023 08:00 ET

Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Corporate Update

Aug 7, 2023 07:15 ET

Aclaris Therapeutics | 8-K: Current report

Jun 12, 2023 16:15 ET

Aclaris Therapeutics | 8-K: Current report

Jun 2, 2023 16:05 ET

Aclaris Therapeutics | 8-K: Current report

Jun 1, 2023 16:18 ET

Aclaris Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 8, 2023 16:05 ET